Analyze Diet

Journal of veterinary pharmacology and therapeutics.

Periodical
Pharmacology
Therapeutics
Veterinary Medicine
Drug Therapy
Publisher:
Blackwell Scientific Publications.
Frequency: Bimonthly
Country: England
Language: English
Author(s):
American College of Veterinary Pharmacology & Therapeutics., Association for Veterinary Clinical Pharmacology and Therapeutics., European Association for Veterinary Pharmacology and Toxicology.
Start Year:1978 -
ISSN:
0140-7783 (Print)
1365-2885 (Electronic)
0140-7783 (Linking)
Impact Factor
1.3
2022
NLM ID:7910920
(DNLM):J41230000(s)
(OCoLC):04580359
Coden:JVPTD9
Classification:W1 JO97Q
Pharmacokinetics of cefoperazone in horses.
Journal of veterinary pharmacology and therapeutics    February 1, 1996   Volume 19, Issue 1 39-43 doi: 10.1111/j.1365-2885.1996.tb00006.x
Soraci AL, Mestorino ON, Errecalde JO.The pharmacokinetics and bioavailability of cefoperazone (CPZ) were studied following intravenous (IV) and intramuscular (IM) administration of single doses (30 mg/kg) to horses. Concentrations in serum, urine and synovial fluid samples were measured following IV administration. CPZ concentrations in serum, synovial fluid and spongy bone samples were measured following IM administration. After IV administration a rapid distribution phase (t1/2 (alpha): 4.22 +/- 2.73 min) was followed by a slower elimination phase (t1/2(beta) 0.77 +/- 0.19 h). The apparent volume of distribution was 0.68 +/- 0....
Characterization of a sterile soft-tissue inflammation model in thoroughbred horses.
Journal of veterinary pharmacology and therapeutics    February 1, 1996   Volume 19, Issue 1 44-49 doi: 10.1111/j.1365-2885.1996.tb00007.x
Guthrie AJ, Short CR, Swan GE, Mülders MS, Killeen VM, Nurton JP.This paper describes the use of subcutaneously-placed tissue chambers as a sterile soft-tissue inflammation model in Thoroughbred horses. Acute, non-immune inflammation was initiated by injecting a sterile lambda carrageenan solution into a tissue chamber. This model was used to study the temporal changes in oxygen and carbon dioxide tensions, pH, bicarbonate, protein, albumin, prostaglandin E2 (PGE2) and leukotriene B4 (LTB4) concentrations, cell counts and differential counts in tissue fluid from inflamed tissue chambers and control chambers. Skin temperatures over control and inflamed chamb...
A review of the pharmacology, pharmacokinetics, and regulatory control in the US of local anaesthetics in the horse.
Journal of veterinary pharmacology and therapeutics    December 1, 1995   Volume 18, Issue 6 397-406 doi: 10.1111/j.1365-2885.1995.tb00616.x
Harkins JD, Stanley S, Mundy GD, Sams RA, Woods WE, Tobin T.No abstract available
The pharmacokinetics or oral and intravenous allopurinol and intravenous oxypurinol in the horse.
Journal of veterinary pharmacology and therapeutics    December 1, 1995   Volume 18, Issue 6 451-456 doi: 10.1111/j.1365-2885.1995.tb00625.x
Mills PC, Dunnett M, Smith NC.The pharmacokinetics of oral and intravenous allopurinol was studied in five horses and compared with intravenous oxypurinol. The plasma concentration vs. time curves, following intravenous administration of 5 mg/kg, were best described by the biexponential equations Cp = 106.58e(-25.14t) + 159.93e(-10.96t) for allopurinol and Cp = 321.09e(-9.72t) + 82.39e(-0.44t) for oxypurinol, with an elimination half-life (t1/2 beta) of 0.09 h and an area under the curve (AUC) of 19.8 mumol.h/L after intravenous administration, while the t1/2 beta and AUC of oxypurinol were 1.09 h and 231 mumol.h/L, respec...
The dose-related effects of phenylbutazone and a methylprednisolone acetate formulation (Depo-Medrol) on cultured explants of equine carpal articular cartilage.
Journal of veterinary pharmacology and therapeutics    December 1, 1995   Volume 18, Issue 6 429-437 doi: 10.1111/j.1365-2885.1995.tb00621.x
Jolly WT, Whittem T, Jolly AC, Firth EC.The dose-related effects of phenylbutazone and Depo-Medrol on chondrocyte viability and chondrocyte-mediated synthesis and depletion of proteoglycans were investigated using cultured explants of equine middle carpal joint articular cartilage. Explants from 12 horses (941 x 3 mm diameter) were cultured for a total of 5 days, which included 3 days' exposure to either phenylbutazone (0, 2, 20, 200 or 2000 micrograms/mL) or Depo-Medrol (0, 20, 200 or 2000 micrograms/mL). For each explant, amino sugar content was used as a measure of proteoglycan content, 35S incorporation as a measure of the rate ...
Influence of formulation on the pharmacokinetics and bioavailability of racemic ketoprofen in horses.
Journal of veterinary pharmacology and therapeutics    December 1, 1995   Volume 18, Issue 6 446-450 doi: 10.1111/j.1365-2885.1995.tb00624.x
Landoni MF, Lees P.The bioavailability of S(+) and R(-) ketoprofen (KTP) in six horses was investigated after oral administration of the racemic (rac) mixture. Two oral formulations were studied, an oil-based paste containing micronised rac-KTP and powder from the same source in hard gelatin capsules, each at a dose rate of 2.2 mg/kg. For the oil-based paste two feeding schedules were used; horses were either allowed free access to food or access to food was restricted for 4 h before and 5 h after dosing. The drug in hard gelatin capsules was administered to horses with restricted access to food. After intraveno...
The effect of xylazine on equine muscle surface capillary blood flow.
Journal of veterinary pharmacology and therapeutics    October 1, 1995   Volume 18, Issue 5 388-390 doi: 10.1111/j.1365-2885.1995.tb00611.x
Hennig GE, Court MH, King VL.No abstract available
Pharmacokinetics of oxytetracycline administered intravenously to 4 to 5-day-old foals.
Journal of veterinary pharmacology and therapeutics    October 1, 1995   Volume 18, Issue 5 375-378 doi: 10.1111/j.1365-2885.1995.tb00607.x
Papich MG, Wright AK, Petrie L, Korsrud GO.No abstract available
A non-invasive and quantitative method for the study of tissue injury caused by intramuscular injection of drugs in horses.
Journal of veterinary pharmacology and therapeutics    June 1, 1995   Volume 18, Issue 3 226-235 doi: 10.1111/j.1365-2885.1995.tb00583.x
Toutain PL, Lassourd V, Costes G, Alvinerie M, Bret L, Lefebvre HP, Braun JP.The present study was undertaken to measure the weight of muscle destroyed by an intramuscular injection of phenylbutazone (PBZ) in horses. In six horses, CK disposition parameters were evaluated after intravenous (i.v.) and intramuscular (i.m.) administration of a CK horse preparation. The same horses received PBZ, a potentially irritating agent, by i.v. and i.m. (neck and hindquarter) routes. Data were analysed using compartmental approaches and instantaneous CK flux was calculated using a discrete deconvolution method. For a 150 U/kg CK dose, the steady-state volume of distribution was 0.05...
Pharmacokinetics and metabolism of amitraz in ponies and sheep.
Journal of veterinary pharmacology and therapeutics    June 1, 1995   Volume 18, Issue 3 210-215 doi: 10.1111/j.1365-2885.1995.tb00580.x
Pass MA, Mogg TD.Amitraz and its active metabolite BTS27271 were given intravenously to ponies and sheep at equimolar doses of 1 mg/kg and 0.68 mg/kg, respectively, and the plasma concentrations of amitraz and BTS27271 estimated at various times thereafter. Amitraz was hydrolysed to BTS27271 in both species. Amitraz was undetectable in sheep plasma after approximately 5 min but persisted in the plasma of ponies for at least 90 min. The persistence of unmetabolized amitraz in ponies may have implications for the toxicity of amitraz in that species. The primary and secondary disposition half-lives of amitraz in ...
Pharmacokinetics of ketoprofen in healthy horses and horses with acute synovitis.
Journal of veterinary pharmacology and therapeutics    June 1, 1995   Volume 18, Issue 3 187-195 doi: 10.1111/j.1365-2885.1995.tb00577.x
Owens JG, Kamerling SG, Barker SA.The pharmacokinetic properties of a single intravenous dose of ketoprofen (2.2 mg/kg) in plasma and synovial fluid were compared in four healthy animals and four horses with experimentally induced acute synovitis. Synovitis was induced by the injection of a 1% solution of sterile carrageenan into the left intercarpal joint. Ketoprofen was administered at the same time as carrageenan infection. The plasma disposition followed a biexponential equation or a two-compartment model in most horses. The plasma harmonic mean half-life in healthy horses (0.88 h) was longer than in horses with synovitis ...
Kinetics, dose response, tachyphylaxis and cross-tachyphylaxis of vascular leakage induced by endotoxin, zymosan-activated plasma and platelet-activating factor in the horse.
Journal of veterinary pharmacology and therapeutics    June 1, 1995   Volume 18, Issue 3 204-209 doi: 10.1111/j.1365-2885.1995.tb00579.x
Mills PC, Ng JC, Seawright AA, Auer DE.Vascular leakage induced by intradermal injection of endotoxin, zymosan-activated plasma (ZAP) and platelet-activating factor (PAF) was measured in nine Thoroughbreds using 125-iodine human serum albumin (125I-HSA) as a marker in the blood. ZAP and PAF produced dose-dependent increases in vascular permeability with the maximum occurring within the first 15 min after injection. The vascular leakage induced by endotoxin was also dose-dependent, but the maximum occurred 2 h after intradermal injection. Intradermal sites previously injected with endotoxin were refractory to a second injection of e...
The disposition of gentamicin in equine plasma, synovial fluid and lymph.
Journal of veterinary pharmacology and therapeutics    April 1, 1995   Volume 18, Issue 2 124-131 doi: 10.1111/j.1365-2885.1995.tb00565.x
Anderson BH, Firth EC, Whittem T.Plasma (P), synovial fluid (SF) and lymph (L) concentrations of gentamicin were studied in two trials. A lymph vessel in the hindlimb was cannulated. The day after surgery (trial A), P and L samples were collected for 12 h after intravenous injection of gentamicin sulphate at 2.2 mg/kg dose rate. Approximately 48 h after surgery (trial B), the fetlock joint of the cannulated hindlimb was catheterized and P, SF and L samples collected for 12 h after a similar intravenous injection. The kinetic parameters were similar to those in other reports and did not differ between trials (P < 0.05). The...
Proteoglycan metabolism of equine articular cartilage and its modulation by insulin-like growth factors.
Journal of veterinary pharmacology and therapeutics    April 1, 1995   Volume 18, Issue 2 141-149 doi: 10.1111/j.1365-2885.1995.tb00568.x
Platt D, Bayliss MT.The effect of human recombinant insulin-like growth factor 1 (rhIGF-1) on proteoglycan (PG) metabolism of full thickness equine articular cartilage explants was investigated. PG synthesis was stimulated at all ages, but higher concentrations of rhIGF-1 were required for maximal stimulation of adult cartilage. There were no changes in the hydrodynamic size, electrophoretic heterogeneity or composition of proteoglycans isolated from rhIGF-1-stimulated cartilage. rhIGF-1 reduced the rate of turnover of both newly synthesized and endogenous proteoglycans in all ages of cartilage investigated. The ...
Pharmacokinetics of ketoprofen after multiple intravenous doses to mares.
Journal of veterinary pharmacology and therapeutics    April 1, 1995   Volume 18, Issue 2 108-116 doi: 10.1111/j.1365-2885.1995.tb00563.x
Sams R, Gerken DF, Ashcraft SM.The pharmacokinetics and urinary excretion of ketoprofen in six healthy mares after the first and last of five daily intravenous doses of 2.2 mg of ketoprofen per kg body weight were investigated using a high-performance liquid chromatographic (HPLC) method for determining plasma and urinary ketoprofen concentrations. Plasma ketoprofen concentrations declined triexponentially after each dose with no significant differences in plasma concentrations or pharmacokinetic parameter values between the first and last doses. The harmonic mean of the terminal elimination half-life of ketoprofen after th...
Intravenous disposition kinetics, oral and intramuscular bioavailability and urinary excretion of norfloxacin nicotinate in donkeys.
Journal of veterinary pharmacology and therapeutics    April 1, 1995   Volume 18, Issue 2 101-107 doi: 10.1111/j.1365-2885.1995.tb00562.x
Lavy E, Ziv G, Glickman A.An aqueous solution of norfloxacin nicotinate (NFN) was administered to donkeys (Aquus asinus) intravenously (once at 10 mg/kg), intramuscularly and orally (both routes once at 10 and 20 mg/kg, and for 5 days at 20 mg/kg/day). Blood samples were collected at predetermined times after each treatment and urine was sampled after intravenous drug administration. Serum NFN concentrations were determined by microbiological assay. Intravenous injection of NFN over 45-60 s resulted in seizures, profuse sweating and tachycardia. The intravenous half-life (t1/2 beta) was 209 +/- 36 min, the apparent vol...
Pharmacokinetics of trimethoprim/sulphachlorpyridazine in horses after oral, nasogastric and intravenous administration.
Journal of veterinary pharmacology and therapeutics    February 1, 1995   Volume 18, Issue 1 47-53 doi: 10.1111/j.1365-2885.1995.tb00550.x
van Duijkeren E, Vulto AG, Sloet van Oldruitenborgh-Oosterbaan MM, Kessels BG, van Miert AS, Breukink HJ.In the present study, the pharmacokinetic parameters of a trimethoprim/sulphachlorpyridazine preparation following intravenous administration, administration by nasogastric tube and administration with concentrate were determined in the horse. Eight adult horses were dosed at 1 week intervals in a sequentially designed study at a dose of 5 mg/kg trimethoprim (TMP) and 25 mg/kg sulphachlorpyridazine (SCP) on all occasions. Plasma concentrations of both drugs were measured serially for 48 h. Pharmacokinetic parameters of clinical importance (distribution and elimination half-lives, clearance, bi...
Pharmacokinetics of ciprofloxacin in ponies.
Journal of veterinary pharmacology and therapeutics    February 1, 1995   Volume 18, Issue 1 7-12 doi: 10.1111/j.1365-2885.1995.tb00543.x
Dowling PM, Wilson RC, Tyler JW, Duran SH.The pharmacokinetics of ciprofloxacin was investigated in healthy, mature ponies. Ciprofloxacin was administered intravenously to six ponies at a dose of 5 mg per kg body weight. Seven days later, ciprofloxacin was administered orally to each pony at the same dose. Intravenous ciprofloxacin concentration vs. time data best fit a two-compartment open model with first-order elimination from the central compartment. Mean plasma half-life, based on the terminal phase, was 157.89 min (harmonic mean). Total body clearance of ciprofloxacin was 18.12 +/- 3.99 mL/min/kg. Volume of distribution at stead...
Haemodynamic effects of hyoscine-N-butylbromide in ponies.
Journal of veterinary pharmacology and therapeutics    February 1, 1995   Volume 18, Issue 1 13-16 doi: 10.1111/j.1365-2885.1995.tb00544.x
Geimer TR, Ekström PM, Ludders JW, Erichsen DF, Gleed RD.The haemodynamic effects of hyoscine-N-butylbromide (0.30 mg/kg, intravenously) were studied in eight adult ponies in a blinded two-period crossover experiment with repeated measures. Values for heart rate were 63%, 48% and 13% greater than control values at 1, 16 and 46 min, respectively, after administration of hyoscine-N-butylbromide. Cardiac output increased by 16% at 16 min after drug injection. Mean right atrial pressure was decreased by 79%, 63%, 45% and 52% at 1, 16, 46 and 61 min, respectively, after drug administration. Stroke volume was decreased by 32% at 1 min and pulmonary arteri...
Comparison of theophylline pharmacokinetics in yearling and 4-year-old horses.
Journal of veterinary pharmacology and therapeutics    December 1, 1994   Volume 17, Issue 6 473-476 doi: 10.1111/j.1365-2885.1994.tb00280.x
Perez Y, Puigdemont A, Cristofol C, De Mora F, Arboix M.No abstract available
A comparative study of the pharmacokinetics of intravenous and oral trimethoprim/sulfadiazine formulations in the horse.
Journal of veterinary pharmacology and therapeutics    December 1, 1994   Volume 17, Issue 6 440-446 doi: 10.1111/j.1365-2885.1994.tb00275.x
van Duijkeren E, Vulto AG, Sloet van Oldruitenborghoosterbaan MM, Mevius DJ, Kessels BG, Breukink HJ, van Miert AS.The biopharmaceutical properties of four fixed trimethoprim/sulfonamide combinations were investigated in the horse. Eight fasted horses were dosed at 1 week intervals in a sequentially designed study with one intravenous (i.v.) and three oral trimethoprim/sulfadiazine (TMP/SDZ) formulations (1, 2 and 3) administered at a dose of 5 mg/kg trimethoprim (TMP) and 25 mg/kg sulfadiazine (SDZ). Plasma concentrations of each compound were monitored for 48 h. Pharmacokinetic parameters (volume of distribution, bioavailability and total body clearance) for TMP and SDZ were calculated and compared. Afte...
Plasma concentrations and therapeutic efficacy of phenylbutazone and flunixin meglumine in the horse: pharmacokinetic/pharmacodynamic modelling.
Journal of veterinary pharmacology and therapeutics    December 1, 1994   Volume 17, Issue 6 459-469 doi: 10.1111/j.1365-2885.1994.tb00278.x
Toutain PL, Autefage A, Legrand C, Alvinerie M.The purpose of the present study was to establish in the horse the relationship between plasma concentration profiles of phenylbutazone (PBZ) and flunixin meglumine (FM) and their pharmacological effects in order to build a predictive pharmacokinetic/pharmacodynamic (PK/PD) model. In five horses, an experimental arthritis was induced by injecting Freund's adjuvant into a carpal joint. PBZ (4 mg/kg) and FM (1 mg/kg) were injected by the intravenous route as a single intravenous dose in two different trials. Five pharmacodynamic end-points were regularly measured after test article injection usi...
Disposition of human drug preparations in the horse. III. Orally administered alclofenac.
Journal of veterinary pharmacology and therapeutics    October 1, 1994   Volume 17, Issue 5 353-358 doi: 10.1111/j.1365-2885.1994.tb00258.x
Delbeke FT, Landuyt J, Debackere M.Concentrations of the non-steroidal anti-inflammatory drug (NSAID) alclofenac were determined by a sensitive high performance liquid chromatographic procedure in plasma and urine of horses following oral administration of a dose of 3 g. In plasma, alclofenac was present in detectable concentrations for 72 h. The plasma disposition in individual horses was best described by a bi-compartmental model with two successive rate constants ka1 = 0.05 +/- 0.06 h-1 and ka2 = 0.06 +/- 0.01 h-1. Alclofenac half-lives t1/2 alpha and t1/2 beta were 1.0 +/- 0.8 h and 6.9 +/- 1.5 h, respectively. Maximal conc...
In vitro effects of tachykinins on the smooth musculature of horse gut.
Journal of veterinary pharmacology and therapeutics    October 1, 1994   Volume 17, Issue 5 379-383 doi: 10.1111/j.1365-2885.1994.tb00263.x
Belloli C, Arioli F, Beretta C, Madonna M.The contractile effects of the tachykinins eledoisin, substance P and neurokinin A and B were investigated in vitro on circular and longitudinal muscle strips from horse duodenum, ileum and colon. Circular smooth muscle of the small intestine was highly responsive, large intestine circular smooth muscle less so, while longitudinal muscle from all gut segments was much less sensitive. pD2 values and intrinsic activities on small intestine circular muscle indicated differences in receptor distribution between the duodenum and ileum: NK3 and a smaller number of NK2 receptors being present in the ...
Pharmacokinetics of thiopentone in the horse.
Journal of veterinary pharmacology and therapeutics    October 1, 1994   Volume 17, Issue 5 331-338 doi: 10.1111/j.1365-2885.1994.tb00255.x
Abass BT, Weaver BM, Staddon GE, Waterman AW.The pharmacokinetics of thiopentone sodium administered intravenously as a single dose (11 mg/kg) were studied in acepromazine pre-medicated horses and ponies in which anaesthesia was maintained with either halothane (Group 1) or isoflurane (Group 2). The results showed that the disposition kinetics of thiopentone in horses and ponies were best described by a three-compartment open model. In plasma, a very short initial distribution phase in both horses and ponies, half-life 1.4 +/- 1.2 min (mean +/- SD) and 1.3 +/- 0.7 min, respectively, was obtained, which was followed by a second comparativ...
Effects of phenylbutazone on thiamylal disposition and anaesthesia in ponies.
Journal of veterinary pharmacology and therapeutics    October 1, 1994   Volume 17, Issue 5 389-393 doi: 10.1111/j.1365-2885.1994.tb00265.x
Young DB, Ewing PJ, Burrows GE, Lessley BA, Clarke CR, Shawley RV.Phenylbutazone given during the perisurgical period has been reported to increase the intensity and duration of thiamylal anaesthesia in horses. A possible mechanism of competitive plasma protein binding has been suggested. The purpose of the present study was to experimentally reproduce the phenomenon of increased intensity and/or duration of thiamylal anaesthesia and to determine if there is competitive displacement of plasma protein bound thiamylal by phenylbutazone. Six ponies each received one of three treatments, 11 mg/kg intravenous (i.v.) thiamylal; 8.8 mg/kg i.v. phenylbutazone; and 1...
The effects of aspirin and paracetamol on the aggregation of equine blood platelets.
Journal of veterinary pharmacology and therapeutics    October 1, 1994   Volume 17, Issue 5 374-378 doi: 10.1111/j.1365-2885.1994.tb00262.x
Heath MF, Evans RJ, Poole AW, Hayes LJ, McEvoy RJ, Littler RM.The responses of equine blood platelets in citrated platelet-rich plasma to arachidonic acid, U44069 (prostaglandin endoperoxide analogue), adenosine 5'-diphosphate, platelet-activating factor or collagen were investigated by turbidimetric aggregometry. Pre-treatment of the platelets with aspirin (1 mmol/l) or paracetamol (1.3 mmol/l) abolished shape change and aggregation in response to arachidonic acid; decreased the rate of aggregation in response to collagen, with no separate effect on shape change; had no marked effect on aggregation caused by the other agonists; but in no case transforme...
The effects of butorphanol on locomotor activity in ponies: a preliminary study.
Journal of veterinary pharmacology and therapeutics    August 1, 1994   Volume 17, Issue 4 323-326 doi: 10.1111/j.1365-2885.1994.tb00253.x
Nolan AM, Besley W, Reid J, Gray G.No abstract available
Effect of drug formulation and feeding on the pharmacokinetics of orally administered quinidine in the horse.
Journal of veterinary pharmacology and therapeutics    August 1, 1994   Volume 17, Issue 4 275-278 doi: 10.1111/j.1365-2885.1994.tb00245.x
Bouckaert S, Voorspoels J, Vandenbossche G, Deprez P, Remon JP.Quinidine is the drug of choice for the treatment of cardiac arrhythmias in horses. The plasma concentrations vs. time profiles following oral administration of two formulations of quinidine sulphate, an oral solution and an oral suspension paste, were evaluated in nine horses. They received multiple administrations of the oral solution under fed and non-fed conditions and of the paste under non-fed conditions. A loading dose of 20 mg.kg-1 and a maintenance dose of 10 mg.kg-1 quinidine with dosing interval of 6 h were used. The relative bioavailability of the oral solution under fed conditions...
Plasma disposition of amikacin and interactions with gastrointestinal microflora in Equidae following intravenous and oral administration.
Journal of veterinary pharmacology and therapeutics    August 1, 1994   Volume 17, Issue 4 291-298 doi: 10.1111/j.1365-2885.1994.tb00248.x
Horspool LJ, Taylor DJ, McKellar QA.Amikacin was detectable (> 0.02 micrograms/ml) in plasma for 12 h in horses and donkeys and for 8 h in ponies following intravenous (i.v.) administration at a dose rate of 6 mg/kg bodyweight. The elimination half-life (harmonic mean) of amikacin was 2.8, 1.6 and 1.9 h in horses, ponies and donkeys, respectively, and the mean body clearance was relatively slow (45.2, 82.4 and 58.0 ml/h.kg, respectively). A suitable dosage interval for the i.v. administration of amikacin sulphate to horses, ponies and donkeys, at a dose rate of 6 mg/kg, would be every 8 h in horses, and every 6 h in ponies an...
1 … 14 15 16 17 18 … 21